Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

A groundbreaking advancement in the treatment of patients with uncontrolled hypertension (HTN) has been achieved with the recent U.S. Food & Drug Administration (FDA) approvals of two renal denervation (RDN) systems

News | FDA

Renal Denervation Systems Receive FDA Approval, Revolutionizing Treatment for Uncontrolled Hypertension

November 20, 2023 — A groundbreaking advancement in the treatment of patients with uncontrolled hypertension (HTN) has ...

November 20, 2023

Investigators in the Smidt Heart Institute found that electrocardiogram changes picked up over time could indicate increased risk

News | Sudden Cardiac Arrest

Cedars-Sinai Investigators Move Closer to Predicting Sudden Cardiac Arrest

November 17, 2023 — Sudden cardiac arrest remains a deadly and complex condition, but investigators in the Smidt Heart ...

November 17, 2023

BioCardia announces that the Food and Drug Administration (FDA) has approved its proposed CardiAMP Heart Failure II study protocol

News | FDA

BioCardia Announces FDA Approval of CardiAMP Heart Failure II Protocol for Autologous Cell Therapy for Ischemic Heart Failure

November 17, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of cardiova ...

November 17, 2023

Findings will help scientists understand how microgravity impacts the ability of human heart cells to withstand the stresses of space travel

News | Heart Failure

Mount Sinai Bioengineers Send Cardiac Muscle Samples Into Space to Study Heart Cell Biology in Microgravity

November 16, 2023 — Mount Sinai’s Cardiovascular Research Institute is sending bioengineered human heart muscle cells ...

November 16, 2023

In the trial of more than 400 adults with heart failure in Israel, the app predicted the need for hospitalization about three weeks in advance of a heart failure event

News | Heart Failure

AI-phone App Detected Worsening Heart Failure Based on Changes in Patients’ Voices

November 16, 2023 — A smartphone app using artificial intelligence technology to detect changes in the voice of a person ...

November 16, 2023

Innovative new treatment option for patients with uncontrolled hypertension now available in the United States

News | Hypertension

Recor Medical Announces U.S. Launch and First Commercial Cases of Paradise Ultrasound Renal Denervation Therapy

November 15, 2023 — Recor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd. announced the first ...

November 15, 2023

Researchers at the University of Leicester have discovered the mechanism by which cholesterol in our diet is absorbed into our cells

News | Cardiovascular Clinical Studies

Ground-breaking Discovery Could Pave the Way for New Therapies to Prevent Cardiovascular Disease and Stroke

November 15, 2023 — Researchers at the University of Leicester have discovered the mechanism by which cholesterol in our ...

November 15, 2023

Real-world evidence from the AHA Scientific Sessions 2023 demonstrated that Eko's AI doubles valvular heart disease detection sensitivity over traditional methods

News | Wearables

Multicenter Validation of the Novel Vivio System for Non-Invasive Estimation of Elevated Left Ventricular End Diastolic Pressure

November 15, 2023 — Ventric Health, a healthcare technology company and medical device provider focused on ...

November 15, 2023

The global medical technology leader and international medical imaging IT and cybersecurity company are working together to provide clinicians with a thorough workflow integration that spans from orchestration and diagnostics to report generation and result distribution

News | Information Technology

GE HealthCare and Sectra Plan to Leverage Deep Integration to Help Enhance Clinical Efficiency

November 14, 2023 — To help provide clinicians a comprehensive workflow, GE HealthCare is working towards the seamless ...

November 14, 2023

The award recognizes leaders who have made major contributions to the fields of cardiovascular and stroke science

News | Heart Failure

American Heart Association Honors Gladstone President Deepak Srivastava with Distinguished Scientist Award

November 14, 2023 — Deepak Srivastava, MD, president of Gladstone Institutes and a renowned cardiovascular researcher ...

November 14, 2023

News | Artificial Intelligence

Breakthrough Clinical Data: Eko Health's AI Significantly Improves Heart Disease Detection in Primary Care

November 14, 2023 — Eko Health, Inc., a leader in AI technology for heart and lung disease detection, today unveiled new ...

November 14, 2023

Ultromics, a leading health technology company at the forefront of detection of heart failure and its phenotypes, announces a significant development regarding the reimbursement code for its flagship product, EchoGo Heart Failure.

News | Heart Failure

CMS publishes final Clinical APC rule for Ultromics EchoGo Heart Failure

November 13, 2023 — Ultromics, a leading health technology company at the forefront of detection of heart failure and ...

November 13, 2023

Results of a randomized trial presented today at the American Heart Association’s Scientific Sessions 2023, AHA 2023, which compared the effects of high-sodium and low-sodium diets on blood pressure in adults, found that following a low-sodium diet significantly lowered blood pressure in 70%-75% of participants in as little as one week

News | AHA

Reducing Sodium Intake Significantly Lowered Blood Pressure in as Little as One Week, Reports AHA 2023 Late-Breaking Science Abstract

November 11, 2023 — Results of a randomized trial presented today at the American Heart Association’s Scientific ...

November 11, 2023

Zerlasiran showed very significant and durable reductions in lipoprotein(a) of up to 99% Lp(a) levels remained around 90% lower than baseline at study endpoint

News | Cardiovascular Clinical Studies

Silence Therapeutics Announces Positive Topline Results from Phase 1 Multiple Dose Study of Zerlasiran in Subjects with High Lipoprotein(a) and Stable Atherosclerotic Cardiovascular Disease

November 10, 2023 — Silence Therapeutics plc, an experienced and innovative biotechnology company committed to ...

November 10, 2023

Experts from the Smidt Heart Institute at Cedars-Sinai will present on a variety of topics at AHA 2023. Photo by Cedars-Sinai.

News | Atrial Fibrillation

Cedars-Sinai Investigators to Unveil New Heart Research at AHA 2023

November 10, 2023 — Cardiologists, cardiothoracic surgeons and interventionalists from the Smidt Heart Institute at ...

November 10, 2023